KatherineD.CrewMD

Breast Cancer

Assistant Professor, Medicine, Columbia University College of Phys & Surg

Overview of Dr. Crew

Dr. Katherine Crew is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 18 years. Dr. Crew accepts several types of health insurance, listed below. She is one of 375 doctors at New York-Presbyterian Hospital and one of 118 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 100 publications and over 500 citings.

Office
161 Fort Washington Avenue
New York, NY 10032
Book by Phone+1(646) 759-9168

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2002 - 2004
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2002
Columbia University Vagelos College of Physicians and SurgeonsClass of 1999

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2000 - 2026
NJ State Medical License 2022 - 2025

Clinical Trials

Vitamin D in Postmenopausal Women at High Risk for Breast Cancer Start of enrollment: 2009 Jun 01
Completed
Phase 2
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer Start of enrollment: 2009 Sep 01
Completed
Phase 1
Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer Start of enrollment: 2007 Sep 01
Completed
Phase 1
Pre-Surgical Intervention for Targeted Therapies for Breast Cancer Start of enrollment: 2007 Jul 01
Completed
Not Applicable
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
Completed
Not Applicable
Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy Start of enrollment: 2010 Dec 01
Completed
Not Applicable
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy Start of enrollment: 2012 Oct 01
Completed
Phase 2
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors Start of enrollment: 2013 May 01
Completed
Phase 2
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy Start of enrollment: 2013 Aug 01
Terminated
Phase 2
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer Start of enrollment: 2016 Dec 06
Completed
Phase 2
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Start of enrollment: 2016 Jun 14
Completed
Phase 2
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Start of enrollment: 2018 Jan 30
Completed
Phase 2
Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting Start of enrollment: 2016 Nov 01
Completed
Not Applicable
CBPR - BRCA Genetic Testing Among Orthodox Jews Start of enrollment: 2018 Mar 13
Completed
Not Applicable
Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE) Start of enrollment: 2020 Oct 23
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

The association of HIV status with triple-negative breast cancer in patients with breast cancer in South Africa: a cross-sectional analysis of case-only data from a pr...
Jacob Dubner, Alfred I Neugut, Maureen Joffe, Daniel S O'Neil, Oluwatosin A Ayeni
The Lancet. Global Health. 2024-12-01
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.
Davide Serrano, Harriet Johansson, Bjørn-Erik Bertelsen, Sara Gandini, Gunnar Mellgren
Journal of the National Cancer Institute. 2024-12-01
Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer.
Anna Vaynrub, Leila Mishalani, Jayant Raikhelkar, Katherine D Crew
Cardio-Oncology. 2024-10-12

Lectures

Randomized double-blind placebo-controlled biomarker modulation study of vitamin d in premenopausal women at high risk for breast cancer (SWOG S0812).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
2nd Annual Clinical Pearls in Internal Medicine Learn from the Leading Clinician Educators
Columbia University Medical Center, Fort Lauderdale, Florida - 3/24/2013
Columbia University Medical Center Clinical Pearls Of Internal Medicine Learn from the Leading Clinician Educators
Continuing Education, Inc., Fort Lauderdale, Florida - 3/24/2013

Press Mentions

Cancer Center at 50December 23rd, 2021
CUIMC Update - Oct. 11, 2021October 11th, 2021
The Impact of COVID-19 on Breast Cancer Screening: A Peek Behind the Lecture with Dr Katherine CrewMay 11th, 2021
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
GHI PPO
Healthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment